Cargando…
Therapeutic Potential of a Vasopressin V2 Receptor Antagonist for Calcium Channel Blocker-Associated Edema with Vasospastic Angina
Calcium channel blocker- (CCB-) associated peripheral edema does not resolve without CCB discontinuation or dose reduction. However, renin–angiotensin system (RAS) inhibitors have been reported to be effective for CCB-associated edema. We report a case of vasospastic angina with refractory CCB-assoc...
Autores principales: | Toda, Kojiro, Fujino, Masashi, Murai, Kota, Noguchi, Teruo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286935/ https://www.ncbi.nlm.nih.gov/pubmed/35845175 http://dx.doi.org/10.1155/2022/9550006 |
Ejemplares similares
-
A new perspective on calcium channel blockers in vasospastic angina
por: Kim, Hack-Lyoung
Publicado: (2021) -
Comparison of calcium-channel blockers for long-term clinical outcomes in patients with vasospastic angina
por: Kim, Sung Eun, et al.
Publicado: (2021) -
Comparison of various calcium antagonist on vasospastic angina: a systematic review
por: Singh, Jaspal, et al.
Publicado: (2023) -
Vasospastic angina
por: Marzilli, Mario
Publicado: (2019) -
Beta blockers versus calcium channel blockers for provocation of vasospastic angina after drug-eluting stent implantation: a multicentre prospective randomised trial
por: Sawano, Mitsuaki, et al.
Publicado: (2020)